|
Delayed
London S.E.
08:00:21 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 8.904 GBX | +0.37% |
|
-0.90% | +46.94% |
| Current month | -6.82% | ||
| 1 month | -5.79% |
Main features
| IE00BM8R0N95 | Fees | 0.5% | Dividend Policy | Market Cap | |
|---|---|---|---|---|---|
| Currency | GBX | AuM (GBP) | 48.57M | Replication Method | Direct (Physical) |
| Number of securities | 49 | AuM evolution | - | Date of creation | 03/11/2021 |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | Developed markets |
| Theme and Sector | BioTech & Genomics |
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the Index).
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/10/26 | GBX 8.904 | +0.37% | 155 |
| 26/10/26 | GBX 8.871 | +1.18% | 21,453 |
| 23/10/26 | GBX 8.768 | -1.83% | 8,333 |
| 22/10/26 | GBX 8.931 | -3.12% | 12,030 |
| 21/10/26 | GBX 9.219 | +2.60% | 9,388 |
- Stock Market
- ETF
- GNOG ETF
Select your edition
All financial news and data tailored to specific country editions





















